In this sense, the proteasome-activating peptide 1 (PAP1), which increases proteasomal activation by opening the proteasomal catalytic chamber and preventing SOD1 aggregation in an ALS cell line model, has recently been developed [270]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.